Funding round-up: Calida Therapeutics, Alentis Therapeutics, Mosanna Therapeutics, Adcendo

Denmark: Adcendo, a biotech company focused on the development of antibody-drug conjugates (ADCs) for the treatment of cancers with a high unmet medical need, has completed a Series A extension financing, raising €31m (US$34.2m) on top of the €51m Series A financing raised in April 2021. The extension was led by Pontifax Venture Capital and…

You must be a HMI Subscriber to view this content.

Subscribe Now »